Adults with obesity may now move directly from Wegovy 2.4mg to 7.2mg if they need greater weight loss ...
Novo Nordisk NVO announced that the European Commission (EC) has approved a new 7.2 mg once-weekly maintenance dose of Wegovy (semaglutide injection) for adults with obesity. This provides physicians ...
The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...
The emergence of walk-in weight-loss injection services in the UK—where high-street pharmacies now offer “skinny jabs" like ...
This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity … ...
A private weight-loss clinic in London has an oddly serene waiting area. No running machines. There are no inspirational posters with before-and-after photos.